Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients.
Karan WatsDaniel RodriguezKurt W PrinsAdnan SadiqJoshua FogelMark GoldbergerManfred MoskovitsMahsa Pourabdollah TootkaboniJacob ShaniJessen JacobPublished in: Pulmonary circulation (2021)
Right ventricular dysfunction, pulmonary hypertension, and moderate to severe tricuspid regurgitation were associated with increased odds for 30-day inpatient mortality. This study highlights the importance of echocardiography and its clinical utility and prognostic value for evaluating hospitalized COVID-19 patients.
Keyphrases
- pulmonary hypertension
- pulmonary artery
- sars cov
- pulmonary arterial hypertension
- aortic valve
- oxidative stress
- aortic stenosis
- palliative care
- left ventricular
- early onset
- cardiovascular events
- transcatheter aortic valve replacement
- risk factors
- cardiovascular disease
- type diabetes
- heart failure
- metabolic syndrome
- adverse drug